Jasper Therapeutics, Inc. JSPR
Set alert
0.52 USD -0.01 -2.22%
At close · Oct 30
0.52 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
0.5106 Day range 0.5539
0.341 52-week range 2.28
- YTD
- -71.57%
- 1 year
- -76.14%
- Open
- 0.516
- Prev close
- 0.532
- Mkt cap
- 17.31M
- Vol
- 396.13K
- Avg vol
- 498.18K
- EPS
- -1.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5106
- High
- 0.5539
- Forward P/E
- -4.89
- Beta
- 2.20
- Short ratio
- 9.32
- Inst. own
- 100.34%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 13, 2024
- 50-d avg
- 21.46
- 200-d avg
- 21.97
- 1y target
- 68.78
Ownership
Held by insiders 4.98%
Held by institutions 100.34%
Float held by institutions 105.60%
Institutions 113
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Velan Capital Investment Management LP | 9.56% | 1,433,828 | 31.72M | Sep 29, 2024 |
| Soleus Capital Management, L.P. | 8.96% | 1,343,665 | 29.72M | Sep 29, 2024 |
| Carlyle Group Inc. | 7.11% | 1,066,189 | 23.58M | Sep 29, 2024 |
| Qiming U.s. Ventures Management, Llc | 6.19% | 928,964 | 20.55M | Sep 29, 2024 |
| Blackrock Inc. | 5.33% | 800,028 | 17.70M | Sep 29, 2024 |
| Vanguard Group Inc | 4.63% | 694,425 | 15.36M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.67% | 401,219 | 8.87M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.98% | 296,675 | 6.56M | Oct 30, 2024 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 1.58% | 236,841 | 5.24M | Jul 30, 2024 |
| Vanguard Extended Market Index Fund | 1.26% | 188,656 | 4.17M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.77% | 115,362 | 2.55M | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.67% | 100,341 | 2.22M | Oct 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARLYLE GROUP, INC. | Unknown | Purchase | Feb 7, 2024 | 0 |
| EMSTER KURT VON | Director | Sale | Apr 12, 2023 | 21,175 |
| FRENCH ANNA LOUISE | Director | Sale | Apr 13, 2023 | 23,750 |
| LIS WILLIAM DAVID | Director | Sale | Oct 12, 2023 | 53,521 |
| MAHAL JEETINDER SINGH | Chief Operating Officer | Conversion of Exercise of derivative security | Dec 11, 2024 | 25,009 |
| QIMING U.S. HEALTHCARE FUND II, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 26, 2023 | 0 |
Held by funds
2 US ETFs and mutual funds hold JSPR · largest positions